From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.

atibuclimab   Click here for help

GtoPdb Ligand ID: 11326

Synonyms: IC14
Immunopharmacology Ligand
Compound class: Antibody
Comment: Atibuclimab (IC14) is a monoclonal antibody against CD14 [1]. It was developed by ICOS Corporation (acquired by Eli Lilly) and was progressed as a potential COVID-19 therapeutic by Implicit Bioscience.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CD14 molecule Hs Antibody Binding - - - 1,5
⤷ [1,5]